Corticosteroids plus long-acting Beta2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium

International Archives of Allergy and Immunology

Volumn 160, Issue 1, 2012, Pages 27-36

  Kan O, K ^a   Matsumoto, K ^a   Inoue, H ^a,b   Fukuyama, S ^a   Asai, Y ^a   Watanabe, W ^c   Kurokawa, M ^c   Araya, J ^d   Kuwano, K ^d   Nakanishi, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B7 H1; Double stranded RNA; Human airway epithelial cells; Respiratory syncytial virus

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; DOUBLE STRANDED RNA; FLUTICASONE PROPIONATE PLUS SALMETEROL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROGRAMMED DEATH 1 LIGAND 1;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UPREGULATION;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANDROSTADIENES; ANTIGENS, CD274; BUDESONIDE; CELL LINE; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; POLY I-C; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; UP-REGULATION;

EID: 84865588675     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000338430     Document Type: Article

References (36)

1. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ: Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-1411.
2. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K: Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164: 1392-1397. (Pubitemid 33124016)
3. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
4. Global Initiative for Asthma Management and Prevention: NHLBI/WHO Workshop report. National Institutes of Health, National Heart, Lung, and Blood Institute, 2006.
5. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD: Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119: 1105-1110. (Pubitemid 46654175)
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Tolllike receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
7. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737. (Pubitemid 39023305)
8. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
9. Dong H, Zhu G, Tamada K, Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-1369.
10. Barber DL, Wherry EJ, Masopust D, Zhu BG, Allison JP, Sharpe AH: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682-687. (Pubitemid 43237609)
11. Chen L, Zhang Z, Chen W, Li Y, Shi M, Zhang J: B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 2007; 178: 6634-6641. (Pubitemid 46717448)
12. Wilkinson TMA, Donaldson GC, Johnston SL, Openshaw PJM, Wedzicha JA: Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 871-876.
13. Tsuda M, Matsumoto K, Inoue H, Matsumura M, Nakano T, Mori A: Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA. Biochem Biophys Res Commun 2005; 330: 263-270. (Pubitemid 40394961)
14. Heinecke L, Proud D, Sanders S, Schleimer RP, Kim J: Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies. J Allergy Clin Immunol 2008; 121: 1155-1160.
15. Telcian AG, Laza-Stanca V, Edwards MR, Harker JA, Wang H, Bartlett NW: RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis 2011; 203: 85-94.
16. Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y: Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-beta-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011; 300:L391-L401.
17. Zhu Z, Tang WL, Ray A, Wu Y, Einarsson O, Landry ML: Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 1996; 97: 421-430.
18. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Tolllike receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
19. Koarai A, Sugiura H, Yanagisawa S, Ichikawa T, Minakata Y, Matsunaga K: Oxidative stress enhances toll-like receptor 3 response to double-stranded RNA in airway epithelial cells. Am J Respir Cell Mol Biol 2010; 42: 651-660.
20. Chiao PJ, Miyamoto S, Verma IM: Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci USA 1994; 91: 28-32.
21. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M: Involvement of tolllike receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005; 280: 5571-5580. (Pubitemid 40280035)
22. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytical virus-induced chemokine expression in the lower airways: Eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999; 159: 1918-1924. (Pubitemid 29275064)
23. Edwards MR, Johnson MW, Johnston SL: Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006; 34: 616-624.
24. Korn SH, Jerre A, Brattsand R: Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001; 17: 1070-1077. (Pubitemid 32717460)
25. Zhu J, Qiu YS, Majumdar S, Gamble E, Matin D, Turato G: Exacerbations of bronchitis: Bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001; 164: 109-116. (Pubitemid 33151307)
26. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119: 1329-1336. (Pubitemid 32686012)
27. Culley FJ, Pennycook AAJ, Tregoning JS, Dodd JS, Walzl G, Wells TN: Role of CCL5 (RANTES) in viral lung disease. J Virol 2006; 80: 8151-8157. (Pubitemid 44182315)
28. Pace E, Gagliardo R, Melis M, La Grutta S, Ferraro M, Siena L: Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol 2004; 114: 1216-1223. (Pubitemid 39469168)
29. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
30. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290.
31. Maneechotesuwan K, Essilfie-Quaye S, Meah S, Kelly C, Khartonov SA, Adcock IM, Barnes PJ: Formoterol attenuates neutrophilic airway inflammation in asthma. Chest 2005; 128: 1936-1942. (Pubitemid 41507524)
32. Greiff L, Wollmer P, Andersson M, Svensson C, Persson CG: Effects of formoterol on histamine induced plasma exudation in sputum from normal subjects. Thorax 1998; 53: 1010-1013. (Pubitemid 28566998)
33. Proud D, Reynolds CJ, Lichtenstein LM, Kagey-Sobotka A, Togias A: Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 1998; 28: 868-875. (Pubitemid 28335565)
34. Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M: Ligand-independent activation of the glucocorticoid receptor by beta(2)-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999; 274: 1005-1010.
35. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ: Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 2005; 172: 704-712. (Pubitemid 41324225)
36. Lovén J, Svitacheva N, Jerre A, Miller-Larsson A, Korn SH: Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. Eur Respir J 2007; 30: 848-856. (Pubitemid 351194787)